Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Any intervention that addresses these fundamental challenges holds promise for improving outcomes
,
GLP-1 agonists including semaglutides like Ozempic and Wegovy and tirzepatides like Mounjaro and Zepbound were originally intended to treat type 2 diabetes and obesity
This approval reflects Concord Biotech's ongoing commitment to expanding access to high-quality, affordable therapies for patients across critical care settings globally
That broader metabolic action supports both weight loss and improved glucose metabolism , which can be especially helpful for people living with obesity and type 2 diabetes
US$ 28.87
US$ 25.52
US$ 29.90
US$ 24.63
US$ 29.47
US$ 24.81
US$ 22.39
